» Articles » PMID: 32474816

The Landmark Series: Gallbladder Cancer

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2020 Jun 1
PMID 32474816
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Given the rarity of gallbladder carcinoma, level I evidence to guide the multimodal treatment of this disease is lacking. Since 2010, four randomized phase III clinical trials including ABC-02, PRODIGE-12/ACCORD-18, BILCAP, and BCAT, and a single-arm phase II trial (SWOG0809) have been reported on the use of adjuvant strategies for biliary malignancies. These trials have led to the recommendation that patients with resected biliary tract cancer should be offered adjuvant capecitabine chemotherapy and those with R1 margins could be considered for chemoradiotherapy. Because there is no level I evidence to guide neoadjuvant therapy or surgical management, current consensus is based on strong retrospective data. The following review summarizes available trials and highlights the best available evidence that form the basis of consensus statements for the multimodal management of gallbladder carcinoma.

Citing Articles

Body composition as a prognostic factor in cholangiocarcinoma: a meta-analysis.

Zhang L, Wang K, Liu R, Kuang T, Chen C, Yao F Nutr J. 2024; 23(1):145.

PMID: 39548545 PMC: 11568527. DOI: 10.1186/s12937-024-01037-w.


Efficacy and predictors of immune checkpoint inhibitors in patients with gallbladder cancer.

Cheng Z, Yang C, Zhao Q, Zhong J, Zhang J, Jin R Cancer Sci. 2024; 115(6):1979-1988.

PMID: 38487949 PMC: 11145113. DOI: 10.1111/cas.16142.


Post-operative morbidity after neoadjuvant chemotherapy and resection for gallbladder cancer: A national surgical quality improvement program analysis.

Kim M, Stroever S, Aploks K, Ostapenko A, Dong X, Seshadri R World J Gastrointest Surg. 2024; 16(1):95-102.

PMID: 38328312 PMC: 10845287. DOI: 10.4240/wjgs.v16.i1.95.


New trends in diagnosis and management of gallbladder carcinoma.

Pavlidis E, Galanis I, Pavlidis T World J Gastrointest Oncol. 2024; 16(1):13-29.

PMID: 38292841 PMC: 10824116. DOI: 10.4251/wjgo.v16.i1.13.


Adenosquamous carcinoma of the gallbladder: a rare entity and dilemmas in its management.

Zishan M, Tee C BMJ Case Rep. 2023; 16(5).

PMID: 37236675 PMC: 10230927. DOI: 10.1136/bcr-2023-254883.


References
1.
Diehl A, Beral V . Cholecystectomy and changing mortality from gallbladder cancer. Lancet. 1981; 2(8239):187-9. DOI: 10.1016/s0140-6736(81)90366-4. View

2.
Bharathi R, Singh R, Gupta R, Verma G, Kalra N, Kiran K . Female sex hormone receptors in gallbladder cancer. J Gastrointest Cancer. 2015; 46(2):143-8. DOI: 10.1007/s12029-015-9698-z. View

3.
Randi G, Franceschi S, La Vecchia C . Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006; 118(7):1591-602. DOI: 10.1002/ijc.21683. View

4.
Roa I, Araya J, Villaseca M, Roa J, De Aretxabala X, Ibacache G . Gallbladder cancer in a high risk area: morphological features and spread patterns. Hepatogastroenterology. 1999; 46(27):1540-6. View

5.
Diehl A . Gallstone size and the risk of gallbladder cancer. JAMA. 1983; 250(17):2323-6. View